February 21, 2025

Study Links Stress to Immune Changes in Breast Cancer

New research shows chronic stressors like perceived stress, inadequate social support, racial discrimination, and neighborhood deprivation are associated with deleterious changes to systemic and tumor immunity in breast cancer patients, with more pronounced effects in Black women.

Conexiant

February 20, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 18, 2025

USPSTF 2009 Mammography Update Linked to Screening Declines

Researchers examined how the 2009 U.S. Preventive Services Task Force mammography guideline update—which recommended biennial screening only for females aged 50 to 74 years—affected screening rates across socioeconomic and geographic subgroups.

Conexiant

February 17, 2025

Physician Turnover After Private Equity Exits

Researchers found physicians in private equity-exiting practices were less likely to stay and more likely to join larger groups within 2 years.

Conexiant

February 03, 2025

Cancer Symptoms Mistaken for Pregnancy Symptoms Could Lead to Delays in Cancer Diagnosis

Pregnant patients may be at risk of having their cancer symptoms misdiagnosed as pregnancy-related symptoms.

The ASCO Post

January 28, 2025

FDA Approves Enhertu for Metastatic, HR-Positive, HER2-Low or -Ultralow Breast Cancer

Enhertu, a HER2-directed antibody-drug conjugate, was approved by the U.S. Food and Drug Administration for pretreated patients with metastatic HR-positive, HER2-low or HER2-ultralow breast cancer based on results from the DESTINY-Breast06 trial.

Conexiant

January 28, 2025

Study Finds Therapeutic Vaccine Targeting HPV16 Is Safe and Effective in Eradicating Precancerous Cervical Lesions

The investigational therapeutic vaccine Vvax001 was studied in a phase II clinical trial of patients with HPV16-positive grade 3 cervical intraepithelial neoplasia. The vaccine may provide a nonsurgic...

The ASCO Post

December 06, 2023

'Game-Changer’ Intervention for Ovarian Cancer Prevention

Gynecologic oncologist Rebecca Stone and colleagues at Johns Hopkins are leading the way in salpingectomy — a quick, low-risk surgical intervention that can significantly reduce the risk of ovarian cancer.

Johns Hopkins Medicine